Natural Capsules Limited

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the Letter of Offer, Entitlement letter, Abridged Letter of Offer, Application form etc. (the “Issue documents”) hosted on this website in connection with the issue of equity shares on a rights basis by Natural Capsules Limited (the “Company”). The Issue Documents have been made available on this website in electronic form solely to comply with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and SEBI Circular No. SEBI/HO/CFD/DIL2/CIR/P/2020/78 dated May 06, 2020. By accessing the Issue Documents, you agree to follow the following terms and conditions, including any modifications to them from time to time.

Cameo Corporate Services Limited (the “Registrar”) and/or its affiliates are not soliciting any action based on any of the information contained on this website, including the Documents, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security.

The Rights Entitlements and the Rights Equity shares have not been and will not be registered under the united states securities act of 1933, as amended (the “US Securities Act”), or any U.S. State securities laws and may not be offered, sold, resold or otherwise transferred within the United States of America or the territories or possessions thereof (the “United States” or “U.S.”), except in a transaction exempt from the registration requirements of the securities act. the rights entitlements and rights equity shares referred to in the documents are being offered and sold (i) in offshore transactions outside the united states in compliance with Regulation S under the us securities act (“regulation s”) to existing foreign corporate or institutional shareholders, and (ii) in the United States to “Qualified Institutional Buyers” (as defined in rule 144a under the US Securities Act) (“U.S. QIB”) pursuant to section 4(a)(2) of the us securities act. the offering to which the documents relates is not, and under no circumstances is to be construed as, an offering of any rights equity shares or rights entitlement for sale in the united states or as a solicitation therein of an offer to buy any of the said securities, except in each case to persons in the united states who are U.S. QIBS.. Accordingly, the Letter of Offer should not be forwarded to or transmitted in or into the United States at any time.

Neither our Company, nor any person acting on behalf of our Company, will accept a subscription or renunciation from any person, or the agent of any person, who appears to be, or who our Company, or any person acting on behalf of our Company, has reason to believe is, in the United States of America. Envelopes containing an Application Form should not be postmarked in the United States of America or otherwise dispatched from the United States of America or any other jurisdiction where it would be illegal to make an offer under the Letter of Offer, no payments for subscribing for the Rights Equity Shares shall be made from US bank accounts and all persons subscribing for the Rights Equity Shares and wishing to hold such Equity Shares in registered form must provide an address for registration of the Equity Shares in India. Our Company is making this Issue on a rights basis to the Eligible Equity Shareholders and will only through email send the Letter of Offer, the Abridged Letter of Offer and Application Form only to Eligible Equity Shareholders who have provided an Indian address to our Company. Any person who acquires Rights Entitlements or the Rights Equity Shares will be deemed to have declared, warranted and agreed, by accepting the receipt of the Letter of Offer, that (i) it is not and that at the time of subscribing for the Rights Equity Shares or the Rights Entitlements, it will not be, in the United States of America (ii) does not have a registered address (and is not otherwise located) in the United States when the buy order is made and (iii) it is authorized to acquire the Rights Entitlement and the Rights Equity Shares in compliance with all applicable law, rules and regulations.

Our Company, in consultation with the Registrar, reserves the right to treat as invalid any Application Form which: (i) appears to our Company or its agents to have been executed in or dispatched from the United States of America; (ii) does not include the relevant certification set out in the Application Form headed “Overseas Shareholders” to the effect that the person accepting and/or renouncing the Application Form does not have a registered address (and is not otherwise located) in the United States of America, and such person is complying with laws of the jurisdictions applicable to such person in connection with the Issue, among others; or (iii) where our Company believes that the Application Form is incomplete or the acceptance of such Application Form may infringe applicable legal or regulatory requirements; or (iv) where a registered Indian address is not provided, and our Company shall not be bound to issue or allot any Rights Equity Shares in respect of any such Application Form. Rights Entitlement may not be transferred or sold to any person in the United States of America.

The information on this website and the Documents are directed at, are solely intended for distribution to, and use by, shareholders of the Company as on Record Date i.e.,July 13, 2021 (or) for renouncees holding Rights Entitlements in their valid demat accounts, who are a resident of India and eligible to exercise the Rights Entitlements and acquire Rights Equity Shares in accordance with the legal requirements applicable in such shareholder’s jurisdiction and in compliance with all applicable laws and regulations. This website and the Documents should not be reproduced, transmitted or distributed to any other person. By accessing the Documents, you are hereby deemed to represent that you qualify under one of the foregoing criteria.

IF YOU ARE NOT PERMITTED TO VIEW MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.

Please note that Documents downloaded and used for subscription to the Issue in contravention of the above will be rejected with no recourse to the Company, the Registrar, the Lead Manager or any of their respective affiliates.